1. A novel multi-channeled neonatal patient Y-piece device (AFECTAIR) developed as part of an aerosolized lung surfactant administration system to be used with AEROSURF (lucinactant), a form of inhaled lung surfactant.
A novel multi-channeled neonatal patient Y-piece device (AFECTAIR) developed as part of an aerosolized lung surfactant administration system to be used with AEROSURF (lucinactant), a form of inhaled lung surfactant. The AFECTAIR uses fluidic principles to effectively decouple ventilator bias flow from nebulizer flow pathways and provide a more direct route into the airway. Not only does this provide less drug delivered into the expiratory circuit, but by providing a more direct route and hence laminar flow to the airway, less drug impaction may occur in the artificial airways. IMV = intermittent mandatory ventilation. Courtesy Discovery Labs.
Robert M DiBlasi Respir Care 2015;60:
(c) 2012 by Daedalus Enterprises, Inc.